Redox Regulation of Soluble Epoxide Hydrolase by 15-Deoxy-Δ-Prostaglandin J2 Controls Coronary Hypoxic Vasodilation

被引:44
作者
Charles, Rebecca L. [1 ]
Burgoyne, Joseph R. [1 ]
Mayr, Manuel [2 ]
Weldon, Steven M. [3 ]
Hubner, Norbert [4 ]
Dong, Hua [5 ,6 ]
Morisseau, Christophe [5 ,6 ]
Hammock, Bruce D. [5 ,6 ]
Landar, Aimee [7 ]
Eaton, Philip [1 ]
机构
[1] Kings Coll London, St Thomas Hosp, Rayne Inst, Div Cardiovasc,British Heart Fdn,Ctr Excellence, London SE1 7EH, England
[2] Kings Coll London, Sch Med, James Black Ctr, Div Cardiovasc, London SE1 7EH, England
[3] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
[4] Max Delbruck Ctr Mol Med, Berlin, Germany
[5] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA
[6] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA
[7] Univ Alabama, Dept Pathol, Ctr Free Radical Biol, Birmingham, AL 35294 USA
基金
英国医学研究理事会;
关键词
15-deoxy prostaglandin J(2); soluble epoxide hydrolase; redox signaling; hypoxia; ACTIVATED-RECEPTOR-GAMMA; BLOOD-PRESSURE REGULATION; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); PPAR-GAMMA; XANTHINE OXIDOREDUCTASE; LIGANDS; TARGET; INJURY; HEART; PROSTAGLANDIN;
D O I
10.1161/CIRCRESAHA.110.235879
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: 15-Deoxy-Delta-prostaglandin (15d-PG)J(2) is an electrophilic oxidant that dilates the coronary vasculature. This lipid can adduct to redox active protein thiols to induce oxidative posttranslational modifications that modulate protein and tissue function. Objective: To investigate the role of oxidative protein modifications in 15d-PGJ(2)-mediated coronary vasodilation and define the distal signaling pathways leading to enhanced perfusion. Methods and Results: Proteomic screening with biotinylated 15d-PGJ(2) identified novel vascular targets to which it adducts, most notably soluble epoxide hydrolase (sEH). 15d-PGJ(2) inhibited sEH by specifically adducting to a highly conserved thiol (Cys521) adjacent to the catalytic center of the hydrolase. Indeed a Cys521Ser sEH "redox-dead" mutant was resistant to 15d-PGJ(2)-induced hydrolase inhibition. 15d-PGJ(2) dilated coronary vessels and a role for hydrolase inhibition was supported by 2 structurally different sEH antagonists each independently inducing vasorelaxation. Furthermore, 15d-PGJ(2) and sEH antagonists also increased coronary effluent epoxyeicosatrienoic acids consistent with their vasodilatory actions. Indeed 14,15-EET alone induced relaxation and 15d-PGJ(2)-mediated vasodilation was blocked by the EET receptor antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE). Additionally, the coronary vasculature of sEH-null mice was basally dilated compared to wild-type controls and failed to vasodilate in response to 15d-PGJ(2). Coronary vasodilation to hypoxia in wild-types was accompanied by 15d-PGJ(2) adduction to and inhibition of sEH. Consistent with the importance of hydrolase inhibition, sEH-null mice failed to vasodilate during hypoxia. Conclusion: This represents a new paradigm for the regulation of sEH by an endogenous lipid, which is integral to the fundamental physiological response of coronary hypoxic vasodilation. (Circ Res. 2011;108:324-334.)
引用
收藏
页码:324 / 334
页数:11
相关论文
共 35 条
[1]  
[Anonymous], 2009, CANCER BIOL THER
[2]   Inhibition of the Soluble Epoxide Hydrolase by Tyrosine Nitration [J].
Barbosa-Sicard, Eduardo ;
Froemel, Timo ;
Keserue, Benjamin ;
Brandes, Ralf P. ;
Morisseau, Christophe ;
Hammock, Bruce D. ;
Braun, Thomas ;
Krueger, Marcus ;
Fleming, Ingrid .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (41) :28156-28163
[3]   Transnitrosylating Nitric Oxide Species Directly Activate Type I Protein Kinase A, Providing a Novel Adenylate Cyclase-independent Cross-talk to β-Adrenergic-like Signaling [J].
Burgoyne, Joseph R. ;
Eaton, Philip .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (43) :29260-29268
[4]   Protein sulfenation as a redox sensor -: Proteomics studies using a novel biotinylated dimedone analogue [J].
Charles, Rebecca L. ;
Schroeder, Ewald ;
May, Georgina ;
Free, Paul ;
Gaffney, Piers R. J. ;
Wait, Robin ;
Begum, Shajna ;
Heads, Richard J. ;
Eaton, Philip .
MOLECULAR & CELLULAR PROTEOMICS, 2007, 6 (09) :1473-1484
[5]   The soluble epoxide hydrolase as a pharmaceutical target for hypertension [J].
Chiamvimonvat, Nipavan ;
Ho, Chin-Min ;
Tsai, Hsing-Ju ;
Hammock, Bruce D. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (03) :225-237
[6]   Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut [J].
Cuzzocrea, S ;
Pisano, B ;
Dugo, L ;
Ianaro, A ;
Patel, NSA ;
Di Paola, R ;
Genovese, T ;
Chatterjee, PK ;
Di Rosa, M ;
Caputi, AP ;
Thiemermann, C .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (02) :366-376
[7]   Peroxisome proliferator-activated receptors and acute lung injury [J].
Cuzzocrea, Salvatore .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (03) :263-270
[8]   Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart [J].
Eaton, P ;
Li, JM ;
Hearse, DJ ;
Shattock, MJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (03) :H935-H943
[9]   Protein thiol oxidation in health and disease: Techniques for measuring disulfides and related modifications in complex protein mixtures [J].
Eaton, Philip .
FREE RADICAL BIOLOGY AND MEDICINE, 2006, 40 (11) :1889-1899
[10]   15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA [J].
FORMAN, BM ;
TONTONOZ, P ;
CHEN, J ;
BRUN, RP ;
SPIEGELMAN, BM ;
EVANS, RM .
CELL, 1995, 83 (05) :803-812